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Abstract
Background: Many contradictory conclusions pertaining to the telomere length in peripheral leukocyte chromosomes as a potential biomarker for ischemic stroke (IS) risk have been reported by the various observational studies in
previous years. This study aims to investigate whether the leukocyte telomere length is associated with an increased
IS risk or not, based on the Mendelian randomization (MR) approach.
Methods: Based on the NHGRI-EBI GWAS Catalog database, the Chinese online genetic database as well as the
previous published studies, twelve single nucleotide polymorphisms (SNPs) with minor allele frequency ≥ 0.05 were
selected and the leukocyte telomere length was measured in 431 first-ever IS patients and 304 healthy controls
(quantitative polymerase chain reaction). To explore linear and non-linear effect of telomere length on the IS risk, we
preformed the linear MR analysis (the inverse-variance weighted method, the maximum likelihood method, and the
mode-based estimation method), and the non-linear MR analysis (semiparametric method with three tests for nonlinearity, including the quadratic test, Cochran’s Q test, and the fractional polynomial test).
Results: Two verified SNPs (rs11125529 and rs412658) were chosen as instrumental variables. In linear MR analysis,
the adjusted odds ratios and 95% confidence intervals of IS for genetically predicted telomere lengths, based on
the two SNPs, were 1.312 (0.979 to 1.759), 1.326 (0.932 to 1.888) and 1.226 (0.844 to 1.781) for the inverse-variance
weighted method, the maximum likelihood method, and the mode-based estimation method, respectively. Three
tests for nonlinearity failed to reject the null exactly, indicating that the relationship between telomere length and IS
risk is unlikely to be non-linear.
Conclusion: This MR study based on individual data does not provide strong evidence for a positive linear or nonlinear effect of telomere length on the IS risk.
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Background
In China, stroke is one of the leading causes of death, and
about 78% of all strokes are ischemic stroke (IS) [1]. IS
is a complex syndrome triggered by cerebral embolism,
with its major etiological subtypes being large artery
stroke, cardioembolic stroke as well as the small vessel
stroke [2]. Chronological age is one of critical factors in
IS pathology but is not considered to be a causal factor
[3]. This relationship might reflect the impact of biological aging, particularly, in regards to the accumulation of
endothelial and vascular damage over time [4]. Telomeres
are specialized DNA–protein complexes at linear chromosome ends in eukaryotes, and have been considered
as a marker of biological aging at both the cellular and
organism level [5, 6]. They safeguard genome stability by
preventing DNA degradation and fusion at chromosomal
termini [7]. The DNA component that include TTAGGG
nucleotide repeats progressively shortens with each cell
division. Telomere shortening to a critical length eventually induces cell senescence and programmed cell death,
thereby they can be likened to a ‘mitotic clock’ reflecting
the amount of cellular turnover within an individual [7].
Furthermore, the telomere attrition rate increased due
to oxidative stress and inflammation, both of which are
implicated as major mechanisms underlying biological
aging [8–10]. Because of its presumed effect on biological aging, telomere length (TL) has been proposed as a
potential biomarker for IS [11]. In addition to biological
aging, TL shortening has been linked to various risk factors of stroke, including obesity, smoking, alcohol intake,
psychological stress and depression [11].
Conventional observational studies have shown inconclusive associations of telomere shortening and the risk
of stroke. Consistently, several original studies reported
positive association between telomere shortening and the
risk of stroke [12–14]. In contrast, evidence also suggests
that shorter telomeres were not significantly associated
with stroke risk [15–17]. However, meta-analysis have
shown that there were less certain results to support the
relationship between TL and stroke [18, 19].
Randomized controlled trials of interventions specific
to TL have not yet been done in relation to stroke outcomes. In the absence of such trials, Mendelian randomization (MR) analysis focused on genetic instrument can
be used to investigate the causality from routinely observational studies [20]. Based on two-sample MR design,
three MR analyses have been performed to investigate
the association between shorter telomeres and stroke
risk and showed contradictory conclusions. First, a MR

study showed that shorter telomeres lead to a marginally significantly decreased odds of stroke in individuallevel data [21]. Another two MR studies suggested that
TL may be a marker of IS and its subtypes rather than
a cause [22, 23]. Two-sample MR typically assume that
the exposure-outcome association is linear or log-linear
[24]. Therefore, a non-linear TL-IS relationship, such as
U-shaped, cannot be detected through this design. To
tackle this nonlinearity problem, one-sample MR analysis
can be used to explore the non-linear effect relating TL to
IS [25]. In this present study, we performed one-sample
MR analysis with individual-level data in a Han Chinese
population to decipher the linear and non-linear causal
role of TL in the IS risk, and to provide insight into the
potential mechanisms.

Methods
Study population

All participants were recruited from Jidong Oil-field
Hospital, Chinese National Petroleum, and Beijing Tiantan Hospital, Capital Medical University, during 2010–
2013. A total of 755 participants aged 18 or above were
found to be eligible. All participants who met any of the
following criteria were excluded from the study: (1) history of mental illness or infectious disease; (2) history of
aneurysm caused by cerebral infarction, cerebral haemorrhage or other cerebrovascular diseases, congenital
heart disease, acute myocardial infarction, liver disease,
renal failure, malignant tumour, chronic obstructive pulmonary disease, rheumatoid arthritis, or other diseases;
and (3) pregnant or lactating women. All first‐ever IS
patients were diagnosed according to the World Health
Organization criteria [26]. In this study, 20 participants
of non-Han Chinese descent were subsequently excluded.
A total of 431 patients with IS and 304 healthy subjects
were included in the final analysis.
This study was approved by the Ethics Committee of
Capital Medical University, China (No. 2016SY23). This
study was in accordance with the principles of the Declaration of Helsinki. All participants provided their written
informed consent before taking part in this study.
Leukocyte telomere length measurement

Blood samples were collected and processed according to the standardized protocol. Following 10 h. of
overnight fasting, blood samples were collected by
venipuncture in two different tubes containing an anticoagulant and a coagulant respectively. Samples were
processed within 8 h. and stored at -80C until further
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measurement. Given that whole blood TL is a proxy
for tissue-specific TL for many tissues, and blood TL is
a proxy for TL in some tissues in epidemiological studies [27], in this study we measured TL in whole blood,
but not different types of leukocytes.
Serum samples were used to measure the biochemical indices, and blood cells were used to extract the
genomic DNA. Based on automated nucleic acid
purification platform (BioTeke, AU1001-32, Beijing,
China), genomic DNA was extracted from the 200 μl
of frozen blood cells using the magnetic bead-based
method for concentrating DNA (The Genomic DNA
Magnetic Beads Kit, AU18016, BioTeke, Beijing,
China). DNA concentration and purity were determined using a Nanodrop (ND-8000, Thermo Scientific, USA) and then normalized to 5 ng/μl in TE buffer
(1 mM EDTA, 10 mM Tris–HCl [pH 8.0]). Absolute
TL of each chromosome end of the peripheral leukocytes was measured by using a validated quantitative
polymerase chain reaction (qPCR) on the method
reported by O’Callaghan with modification [28, 29].
A single copy reference gene (36B4) which encodes
the acidic ribosomal phosphoprotein P0, was used to
normalize the quantity of the input DNA. Comparing
telomere-to-36B4 ratio to reference DNA of known
TL reflects the absolute length of the telomeres. The
master mix was prepared using Applied Biosystems
reagents. Primer concentrations were: TelF 200 nM,
TelR 200 nM, 36B4F 300 nM, and 36B4R 500 nM. The
primer sequences (5′–3′) were as follows:
TelF CGGTTTGTTTGGGTTTGGGTTTGGGTTTGG
GTTTGGGTT
TelR GGCTTGCCTTACCCTTACCCTTACCCTTAC
CCTTACCCT
36B4F CAGC AAGTGG GAAGGTGTA ATCC
36B4R CCCATTC TATCATCAACGG GTACAA
Analysis of both telomere and 36B4 in experimental samples and reference DNA were run in triplicates
using 5 ng DNA and both telomere and 36B4 amplifications were performed on the same run. A no template control of nuclease-free water was included in
each run. In brief, qPCR was performed in 0.1 ml tubes
on the Applied Biosystems QuantStudio 3 Real-Time
PCR System (Thermo Scientific, USA), with the thermal cycling profile for both telomere and 36B4 amplifications: 2 min at 50 °C, 2 min at 95 °C, followed by 35
cycles of 95 °C for 15 s, 61 °C for 1 min, followed by a
melt curve. The no template controls in all runs were
no amplification. The melt curve should produce only
one single distinct peak. Standard deviation for the Ctvalue in replicates were less than 0.5. The inter-coefficients of variance for the Ct-value was less than 5%.
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Genotyping

Single nucleotide polymorphisms (SNPs) were selected
from the NHGRI-EBI GWAS Catalog (https://www.ebi.
ac.uk/gwas) and the online genetic database (https://
www.ensembl.org) according to reported associations
with TL and minor allele frequency (MAF) ≥ 0.05. Only
one SNP (rs17653722) is reported in population of Chinese descent and other TL-related SNPs were based on
the European ancestry. The exclusion of association
could be confirmed in online software PhenoScanner
(https ://www.phenoscanner.medschl.cam.ac.uk/pheno
scanner). Finally, twelve SNPs (rs11125529, rs6772228,
rs10936599,
rs7726159,
rs9420907,
rs17653722,
rs3027234, rs8105767, rs409627, rs412658, rs6028466,
rs755017) were selected for analysis. SNP genotyping was
performed on these SNPs using the Sequenom Massarray
iPLEX platform (Agena Bioscience, Inc., San Diego, CA,
USA).
Variables

Demographic characteristics of participants including age, gender, smoking, drinking, height, weight, body
mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), were collected by questionnaire survey and physical examination. Biochemical data
including fasting plasma glucose (FPG), triglycerides
(TG), total cholesterol (TC), high‐density lipoprotein
cholesterol (HDL‐C), low‐density lipoprotein cholesterol
(LDL‐C), apolipoprotein A1 (ApoA1), apolipoprotein B
(ApoB) were all tested via standard methods in the clinical laboratory of Beijing Tiantan Hospital. TL measurement and SNP genotyping were performed by laboratory
personnel according to the standardized protocol.
Statistical analysis

Demographic and clinical characteristics were represented as the mean ± standard deviation (SD) for continuous variables underlying the normal distribution;
otherwise, the median (interquartile range) was used.
Categorical variables were represented as frequency (percentage). The between-group differences of continuous
variables were tested by the t test or the Mann–Whitney
U test. The chi‐squared test was used to compare the proportions for categorical variables, and to test for Hardy–
Weinberg equilibrium.
The genetic variant or genetic risk score (GRS) acts as
an instrumental variable in MR analysis if: (1) they are
truly associated with TL; (2) they are independent of
other factors (confounders); and (3) they can only influence IS risk via the causal effect of the TL. All association
of instrument variables with TL and other risk factors,
which were susceptible to reverse association, were
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limited to health controls. Principal analyses assumed
over-dominant effects (heterosis), with subsidiary analyses of other genetic models (dominant, recessive, codominant and additive model).
The β coefficients were obtained from the linear regression model with natural log-transformed TL (ln TL).
The percentage difference in TL with risk genotype was
obtained from [exp (β) − 1)] × 100. Then, the linear MR
estimates for ln TL on the IS risk were calculated by the
inverse-variance weighted method, the maximum likelihood method, and the mode-based estimation method,
adjusting for age, sex, and other confounders (smoking
status, drinking status, and levels of BMI, SBP, DBP, FPG,
TG, TC, HDL-C, LDL-C, ApoA1, ApoB). All results were
presented as the odds ratio (OR) of IS per 10% decrease
in TL. Three tests for non-linearity of the semiparametric method (the fractional polynomial method and the
piecewise linear method) were applied: the quadratic
test, which assesses for a linear trend among the localised
average causal effect (LACE) estimates, Cochran’s Q test,
which assesses whether LACE estimates differ more than

would be expected by chance, and the fractional polynomial test, which assesses whether the fractional polynomial model of degree 1 fits LACE estimates better than
the linear model [25].
For all analyses, a two‐tailed P value < 0.05 was considered to be statistically significant. All statistical analyses
were performed using R version 3.5.3 (R Foundation for
Statistical Computing, Vienna, Austria).

Results
Participant characteristics

Demographic and clinical characteristics were described
in Table 1. Among 735 participants (374 men and
361 women), the median age of the study population
was 54 years (P25 44 years, P75 61 years) in all subjects,
47 years (35 to 59 years) in controls, and 57 years (49
to 63 years) in IS patients. Most of the IS patients were
older males with smoking and drinking habits and higher
weight, BMI, SBP, DBP, TG levels and lower TC, HDL‐C,
ApoA1, ApoB levels. The levels of TL, height, FPG,
LDL‐C, and ApoB/ApoA1 ratio were not statistically

Table 1 Characteristics of the study population
Parameters
Age, years

Controls (n = 304)
47 (35, 59)

Cases (n = 431)
57 (49, 63)

Gender, n (%)
Male

130 (42.80)

244 (56.60)

Female

174 (57.20)

187 (43.40)

Smoke, cigarettes/day, n (%)
No

253 (83.20)

248 (57.50)

1–10

29 (9.50)

41 (9.50)

> 11

22 (7.20)

142 (32.90)

221 (72.70)

252 (58.50)

Drink, n (%)
No
Yes
TL, kb
Height, cm

83 (27.30)

P
1.736 × 10–19*

2.404 × 10–4*

1.227 × 10–17*

8.893 × 10–5*

179 (41.50)

6.74 (5.18, 8.43)

6.44 (4.88, 8.93)

0.144

165.0 (159.0, 172.0)

167.0 (160.0, 172.0)

0.324

Weight, kg

66.95 (57.10, 77.58)

70.00 (63.00, 77.80)

0.003*

BMI, kg/m2

24.31 (22.08, 27.16)

25.27 (23.07, 27.39)

0.003*

SBP, mmHg

124 (113, 136)

138 (125, 150)

DBP, mmHg

79 (72, 88)

82 (76, 91)

1.087 × 10–16*

9.324 × 10–7*

FPG, mmol/L

5.00 (4.70, 5.50)

5.17 (4.61, 6.00)

TG, mmol/L

1.26 (0.86, 1.80)

1.34 (1.00, 1.87)

0.017*

TC, mmol/L

4.50 (3.99, 5.05)

4.22 (3.47, 4.99)

HDL‐C, mmol/L

1.19 (1.01, 1.38)

1.08 (0.91, 1.24)

2.451 × 10–4*

LDL‐C, mmol/L

2.53 (2.12, 2.92)

2.46 (1.92, 3.00)

ApoA1, g/L

1.26 (1.14, 1.36)

1.19 (1.07, 1.29)

ApoB, g/L

0.98 (0.85, 1.19)

0.93 (0.73, 1.11)

ApoB/ApoA1 ratio

0.79 (0.66, 1.01)

0.77 (0.61, 0.96)

0.053

5.497 × 10–9*
0.232

1.727 × 10–9*
1.845 × 10–4*
0.198

TL telomere length, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, TG triglycerides, TC total cholesterol,
HDL‐C high‐density lipoprotein cholesterol, LDL‐C low‐density lipoprotein cholesterol, ApoA1 apolipoprotein A1, ApoB apolipoprotein B
* P < 0.05 is statistically significant
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different between groups. There were no statistically
significant differences in the genotype distribution of
all SNP between the IS patients and the control group
(Table 2). Four SNPs with MAF < 0.05 were excluded
(MAF: 0.000 for rs6772228, 0.006 for rs9420907, 0.042
for rs3027234, and 0.002 for rs6028466). SNPs that deviated from Hardy–Weinberg equilibrium were excluded.
Other eight SNPs, amongst the healthy controls, were all
in accordance with the Hardy–Weinberg equilibrium.
Association estimates for individual SNPs

Association of each SNP with ln TL in all the assumed
genetic models are shown in Additional file 1: Table S1

and Additional file 2: Table S2. To meet MR assumptions
basically, two of the SNPs (rs11125529 and rs412658)
were used as instrumental variables, and the unweighted
GRS were constructed for non-linear MR analysis. By
over-dominant model analysis, two SNPs in the control
group were found to be associated with decreased TL,
with risk genotype difference in ln TL of -0.108 (95%
confidence interval (95% CI) − 0.204 to − 0.013) for
rs11125529, − 0.089 (− 0.176 to − 0.001) for rs412658
(Table 3). These two TL-related SNPs were not associated
with the conventional risk factors or other biochemical indicators in the control group (Fig. 1). Furthermore,
these two SNPs displayed no direct evidence for an

Table 2 Genotype distributions of SNPs in IS patients and controls
SNP identifier

Chr

Gene

rs11125529

2

ACYP2

rs10936599

rs7726159

rs17653722

rs8105767

rs409627

rs412658

rs755017

3

5

12

19

19

19

20

Genotype

Controls

Cases

C/C

202 (66.40%)

305 (70.80%)

C/A

92 (30.30%)

112 (26.00%)

A/A

10 (3.30%)

14 (3.20%)

MYNN
T/T

103 (33.90%)

121 (28.10%)

T/C

148 (48.70%)

225 (52.20%)

C/C

53 (17.40%)

85 (19.70%)

C/C

114 (37.50%)

155 (36.00%)

TERT
C/A

147 (48.40%)

195 (45.20%)

A/A

43 (14.10%)

81 (18.80%)

G/G

220 (72.40%)

302 (70.10%)

KRT80
G/T

76 (25.00%)

117 (27.10%)

T/T

8 (2.60%)

12 (2.80%)

A/A

159 (52.30%)

215 (49.90%)

LOC112268248
A/G

125 (41.10%)

177 (41.10%)

G/G

20 (6.60%)

39 (9.00%)

G/G

129 (42.40%)

189 (43.90%)

ZNF676
G/C

145 (47.70%)

192 (44.50%)

C/C

30 (9.90%)

50 (11.60%)

C/C

130 (42.80%)

188 (43.60%)

ZNF676
C/T

143 (47.00%)

190 (44.10%)

T/T

31 (10.20%)

53 (12.30%)

A/A

102 (33.60%)

163 (37.80%)

A/G

147 (48.40%)

199 (46.20%)

G/G

55 (18.10%)

69 (16.00%)

ZBTB46

IS ischemic stroke, SNP single nucleotide polymorphism, Chr chromosome
P < 0.05 is statistically significant
PHWE < 0.05 indicating that the SNP in control group was not satisfied Hardy–Weinberg equilibrium

P

PHWE

0.433

1.000

0.240

1.000

0.252

0.718

0.800

0.654

0.473

0.563

0.639

0.304

0.596

0.441

0.461

0.907
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Table 3 Candidate IVs and their association with TL
and IS risk under over-dominant model
Association with ln TL
in controls
MD (95% CI)
rs11125529
C/C-A/A
C/A
rs412658
C/C-T/T
C/T

Association with IS in all
subjects
P

OR (95% CI)

0.203

0.026*
0.000 (0.000, 0.000)
− 0.108 (− 0.204,
− 0.013)

P

0.000 (0.000, 0.000)
0.810 (0.580, 1.120)
0.428

0.049*

0.000 (0.000, 0.000)
− 0.089 (− 0.176,
− 0.001)

0.000 (0.000, 0.000)
0.890 (0.660, 1.190)

TL telomere length, IS ischemic stroke, MD mean difference, 95% CI 95%
confidence interval, OR Odds ratio
* P < 0.05 is statistically significant

individual association with IS risk (P > 0.05). The ORs for
IS of risk genotype (“short TL”) were 0.810 (0.580, 1.120)
for rs11125529, and 0.890 (0.660 to 1.190) for rs412658
(Table 3).
Association of TL with the IS risk

In this case–control study, the OR (95% CI) for IS was
0.681 (0.469 to 0.982) adjusted for age and sex (Fig. 2).
The association between TL and the IS risk was not statistically significant (OR (95% CI): 0.671 (0.437 to 1.031))
even after further adjusting for the smoking status,

Variables
Age, years
Height, cm
Weight, kg
BMI, kg/m2
SBP, mmHg
DBP, mmHg
FPG, mmol/L
TG, mmol/L
TC, mmol/L
HDL-C, mmol/L
LDL-C, mmol/L
ApoA1, g/L
ApoB, g/L
ApoB/ApoA1
ratio

drinking status, and levels of BMI, SBP, DBP, FPG, TG,
TC, HDL-C, LDL-C, ApoA1, ApoB.
Using rs11125529 and rs412658 as a proxy, the linear
MR analysis provided no evidence of an overall association between genetically predicted TL and IS risk (OR
(95% CI): 1.312 (0.979 to 1.759) for the inverse-variance
weighted method, 1.326 (0.932 to 1.888) for the maximum likelihood method, and 1.226 (0.844 to 1.781)
for the mode-based estimation method), after adjusting for the above-mentioned factors (Fig. 2). Using the
unweighted GRS (rs11125529 and rs412658) as instrumental variables, three tests of nonlinearity MR analysis failed to reject the null hypothesis (P = 0.069 for the
quadratic test, P = 0.126 for the fractional polynomial
test, and P = 0.260 for the Cochran’s Q test), indicating
that the effect of telomere attrition on IS risk may not
be non-linear. In Fig. 3, the box plot of TL between IS
patients and controls across quintiles of the TL was also
shown that there was no obvious non-linear TL-IS relationship. Two of five groups by the quintiles of TL, there
were statistically significant differences in TL between
the IS patients and the controls.

Discussion
Based on linear and non-linear MR analysis, we used TLrelated SNPs (or unweighted GRS) as proxies to clarify
whether TL is causally relevant to IS or not. Our results
showed no causal association between the genetically
shortened TL and the increased IS risk.
Many epidemiologic studies have examined the relationship between TL and stroke risk, but results were

rs11125529 (No. of genotypes: CA/CC-AA, 92/212)
MD (95% CI)
MD (95% CI)
P
-0.537 (-3.597, 2.524)
0.731
-1.934 (-3.919, 0.052)
0.057
-3.082 (-6.296, 0.133)
0.061
-0.545 (-1.481, 0.390)
0.254
0.671 (-4.304, 5.646)
0.792
-0.235 (-3.184, 2.713)
0.876
-0.067 (-0.313, 0.180)
0.595
-0.129 (-0.359, 0.101)
0.273
-0.110 (-0.328, 0.109)
0.325
0.027 (-0.037, 0.092)
0.408
-0.103 (-0.259, 0.054)
0.199
0.013 (-0.025, 0.051)
0.494
-0.115 (-0.266, 0.036)
0.137
-0.100 (-0.231, 0.031)
0.134

rs412658 (No. of genotypes: CT/CC-TT, 143/161)
MD (95% CI)
MD (95% CI)
P
1.925 (-0.885, 4.734)
0.180
-0.273 (-2.111, 1.565)
0.771
-1.559 (-4.530, 1.412)
0.305
-0.494 (-1.355, 0.367)
0.262
-0.985 (-5.563, 3.593)
0.674
-1.661 (-4.369, 1.046)
0.230
-0.041 (-0.268, 0.186)
0.722
-0.193 (-0.404, 0.019)
0.075
-0.007 (-0.209, 0.194)
0.942
0.004 (-0.056, 0.063)
0.908
0.033 (-0.112, 0.177)
0.657
-0.013 (-0.048, 0.022)
0.459
-0.006 (-0.146, 0.133)
0.932
0.004 (-0.117, 0.125)
0.948

Fig. 1 Associations of two single nucleotide polymorphisms related to telomere length with various characteristics in individuals free from known
ischemic stroke at time of measurement. MD mean difference, 95% CI 95% confidence interval, BMI body mass index, SBP systolic blood pressure,
DBP diastolic blood pressure, FPG fasting plasma glucose, TG triglycerides, TC total cholesterol, HDL‐C high‐density lipoprotein cholesterol, LDL‐C
low‐density lipoprotein cholesterol, ApoA1 apolipoprotein A1, ApoB apolipoprotein B.
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P
ln TL (kb)
Adjusted for age, sex
Further adjusted†
Linear MR analysis†
Inverse-variance weighted method
Maximum likelihood method
Mode-based estimation method
Non-linear MR analysis†
The quadratic test
The fractional polynomial test
The Cochran’s Q test

OR (95% CI)

0.041*
0.069

0.681 (0.469, 0.982)
0.671 (0.437, 1.031)

0.069
0.117
0.285

1.312 (0.979, 1.759)
1.326 (0.932, 1.888)
1.226 (0.844, 1.781)

0.069
0.126
0.260

Fig. 2 Estimates of association of telomere length (TL) and genetic prediction telomere with ischemic stroke risk. *P < 0.05 is statistically
significant. † Corrected for regressions of TL and potential confounding factors, including age, sex, smoking status, drinking status, and levels of
body mass index, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, triglycerides, total cholesterol, high‐density lipoprotein
cholesterol, low‐density lipoprotein cholesterol, apolipoprotein A1, apolipoprotein B. OR odds ratio, 95% CI 95% confidence interval, ln TL Natural
log-transformed telomere length, MR mendelian randomization.

Fig. 3 Box plot of telomere length across quintiles of the telomere
length. P < 0.05 is statistically significant

not consistent enough. Shorter TL were not significantly associated with IS in the prospective and retrospective studies carried out in the Caucasian [15, 30,
31]. A nested case–control study including 504 case–
control pairs of American female nurses showed a
non-significant association between relative TL and IS
(lowest vs. highest quartile: OR = 0.82, 95% CI 0.52–
1.32, P = 0.42) [15]. Consistent with findings from the
retrospective study, a prospective study (1,136 American adults aged 65 years and older at baseline, average
6.1 years of follow-up, 33 new cases of IS) reported
that leukocyte TL change did not associate with IS
(1st quartile vs. 4th quartile: relative risk (RR) = 1.61
(95% CI 0.46–5.68; P = 0.46) [30]. Similarly, in a cohort
study including 4,576 Danish at baseline (10 years of

follow-up, 295 new case of IS), the adjusted RR of IS
for TL (4th quartile vs. 1st quartile) were 0.95 (95% CI
0.64–1.40; P = 0.60) [31]. In a case–control study carried out in Wuhan (capital of Hubei Province, South
China), including 1,309 stroke patients and 1,309 ageand sex-matched control subjects, OR (95% CI) for IS
risk were 2.12 (1.62–2.77) compared the first quartile (shortest) to the fourth (longest) quartile [14]. In
another case–control study carried out in Shenzhen
(Guangdong Province, South China) including 150
cases of IS and 150 siblings of patients free of stroke,
shortened TL was independently associated with IS
(OR = 4.00, 95% CI 1.28–12.77) [32]. The present MR
did not provide strong evidence of causal association
between short TL and IS, consistent with findings from
the prospective studies and the retrospective studies
carried out in the Caucasian, while different to case–
control studies performed in the Chinese.
Despite previous retrospective observational studies
reporting an TL-stroke association, such a relationship
has not been firmly supported by evidence from prospective cohort studies. Subgroup analysis of four meta-analysis (stratified by study design) have shown consistent
results that shorter TL were not significantly associated
with stroke risk in prospective studies or in studies with
a high quality score [18, 19, 33, 34]. In a recent metaanalysis, shorter TL was associated with a significant
11% higher risk for stroke (RR = 1.12, 95% CI 1.05–1.19),
although with significant heterogeneity between studies (I2 = 81.1%, Phet < 0.001) [33]. After stratified by study
design, the TL-IS relationship was not significance in
those prospective studies (RR = 1.03, 95% CI 0.96–1.09)
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but remained significant in retrospective studies
(RR = 1.81, 95% CI 1.54–2.13) [33]. MR analysis which
simulates natural experiments based on genetic variants,
is consider as an interface between cohort studies and the
intervention trials at the evidence level [35]. The inconsistency might be explained by the confounding, reverse
causation or recall bias, which might be avoided in MR
analysis but not in observational studies.
Three linear MR studies based on two-sample MR
design also presented inconsistent results in European
ancestry. One MR analysis showed conflicting results
which shorter TL was marginally statistically significantly
associated with the decreased risk of stroke [21]. Another
two linear MR analysis provided no evidence of the linear
association between genetically predicted short TL and
IS as well as its subtypes [22, 23]. Similarly, we also found
null linear relationship between genetically predicted TL
and IS risk in a Han Chinese population.
There are several possible explanations for the discrepancy between retrospective and prospective cohort studies. One hypothesis is that TL had causal effect on IS risk
under certain circumstances. Difference in factors, such
as participant age range, TL measurement technique, and
so on, might influence the TL-IS relationship. A previous
study indicate that the positive association between short
TL and the risk of stroke or post-stroke death might
only exist in the seniors population (ranging from 65 to
73 years old), therefore the effect of age might need to
be taken into consideration in future studies [11]. However, people aged 65–73 years comprised a relatively low
proportion of all participants (9.52%) in our research.
Furthermore, although absolute TL measured by qPCR
showed a strong correlation (r2 = 0.75, P < 0.0001) with
the results obtained with terminal restriction fragment
analysis (the gold standard for TL measurement). However, slightly difference in TL measurement could affect
the TL-IS relationship [28].
Another hypothesis, based on epidemiological evidence, explaining this contradiction is that shorter TL is
inversely associated with the risk of IS, which means that
TL may be a downstream biological consequence of the
IS onset. Figure 3 illustrates that no clear linear or nonlinear relationship exists between TL and the risk of IS.
However, not all of the differences between the TL and
the IS risk were statistically significant within the different TL groups, indicating that there may be a feedback
mechanism within certain TL range. Additionally, age is
one of the major risk factors of TL and IS, so the effect of
age needs to be excluded to prove this hypothesis [7, 11].
Estimates from previous MR studies and our study have
avoided the possibility of inverse association to some
extent, but more work is still needed to be determined
the possible role of TL. For example, bidirectional MR
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analysis may be further used to orient the causal direction of TL-IS relationship [36]. Otherwise, in terms of the
conflicting results from different research designs, other
possibility is that there is no association between TL and
IS risk. At present, however, the mechanism research on
the relationship of TL and IS is still lacking and lagging,
and we cannot rule out the possibility that the existence
of certain compensation mechanisms may have affected
our results.
For the chief strengths of our study, we explored the
possible shape of the potential causal relation between TL
and IS risk in a one-sample MR framework using linear
and non-linear MR methodology. As a result of the MR
analysis, potential reverse causality was eliminated and
confounding bias was reduced because genetic instruments were not associated with individual risk factors
that may affect results from conventional observational
studies. Secondly, although the potential pleiotropic
effects were unavoidable in this study, we searched comprehensively from genotype to phenotype to identify the
potential pleiotropic effects and further provided possible evidence of the SNP instrument validity that the SNPs
have no effect on available confounding factors, to reduce
the likelihood of bias due to violation of the instrumental
variable analysis. Furthermore, to our knowledge, this is
the first linear and non-linear MR study assessing TL in
relation to the IS risk in a Han Chinese population. Otherwise, healthy controls were randomly recruited from
the general population covering same geographical area,
which could decrease the selection bias of the results.
This study also has some limitations. Firstly, MR analysis has stringent assumptions [20]. Completely ruling out
potentially pleiotropic effects or an additional biological causal pathway is a challenge for all MR analyses. We
are limited by current knowledge and other unavailable
confounders, so we cannot exclude the possibility that
our estimates are biased by currently unknown pleiotropic effects. Secondly, insufficient statistical power was
a common limitation of one-sample MR analysis, and
therefore we cannot exclude type II error as an explanation for the null results [37]. Our study does not provide
strong evidence for a positive linear or non-linear effect
of TL on IS, but does not rule out that genetically predicted TL by unidentified genetic instruments might
play a role. Finally, our study was conducted in middle
to early late aged participants of Han Chinese descent
based on Northern China. Further MR research needs to
be explored in a larger and more representative samples,
including those from a non-Asian ethnicity.
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Conclusion
In conclusion, although TL is associated with the risk of
IS based on the conventional case–control analysis, this
one-sample MR study suggests that negative association
of TL with the IS risk is unlikely to be linear or non-linear
causal. There is a need to identify the specific genetic,
biochemical, and environmental biological mechanisms
responsible for this association. Further research with
larger sample sizes, which will be able to perform stratified analysis by age or other strong risk factors, is necessary to understand the causal pathways underpinning
this association.
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